Which statement best describes displacement interactions on albumin during polypharmacy?

• A. Displacement on Albumin Can Alter Free Fraction, Distribution, and Toxicity
• B. Protein Binding Has No Effect on Distribution
• C. Only One Drug Can Bind Albumin at a Time
• D. Displacement Always Reduces Toxicity

Answer: (A)

Displacement interactions at albumin alter the amount of drug that is free in the plasma, which directly affects how the drug distributes in the body and the potential for toxicity. Many drugs bind reversibly to albumin, and only the unbound (free) fraction can cross membranes to tissues, be metabolized, or be excreted. When several tightly bound drugs are present, they can compete for the same binding sites. If one drug is displaced, the free fraction of the displaced drug increases, at least temporarily. That rise in unbound drug can enhance the drug’s pharmacologic effect and raise the risk of toxicity, even if the total drug concentration remains the same. This is especially important in polypharmacy where multiple highly protein-bound medications are used and where small changes in binding can lead to meaningful shifts in active drug levels.

This concept is not consistent with the idea that protein binding has no effect on distribution, nor with the notion that only one drug can bind albumin at a time. It’s also not universally true that displacement reduces toxicity; the outcome depends on the drug’s safety margin and the direction of the change in free concentration.